logo-loader
NASDAQ:ORGS

Orgenesis

Receive alerts
Market:
NASDAQ
Price
0.88 USD
Day Change
11.00%
Market Cap:
$29.92 m
52 weeks high
1.57
52 weeks low
0.25

In brief

Orgenesis Inc is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies.